ACTIVE

APOTHEEK LEFEVER - DE CLOEDT

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result24,1 k €-47,2 %over 1 year
Gross margin199,9 k €-28,1 %over 1 year
Equity699,2 k €+3,6 %over 1 year
Workforce2,0 ETP-9,1 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK LEFEVER - DE CLOEDT is a Public limited company incorporated in 1980. Its registered office is in Knokke-Heist. It employs on average 2,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0421.212.996
Incorporation
24/12/1980
Legal form
Public limited company
Registered office
Dorpsstraat 110
8300 Knokke-Heist · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
2,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin199,9 k €278 k €116,3 k €194,7 k €141,5 k €
EBITDA52,1 k €71,8 k €-40,4 k €62,8 k €19,5 k €
Operating result32 k €40,3 k €-64,7 k €40,7 k €4,7 k €
Net result24,1 k €45,6 k €-56,6 k €34,6 k €6,7 k €
Balance sheet
Equity699,2 k €675,1 k €629,6 k €686,2 k €1,2 M €
Total assets1,2 M €1,2 M €1,3 M €1,4 M €1,6 M €
Cash484,9 k €472,8 k €280,3 k €692,3 k €688,5 k €
Debts482,1 k €509,8 k €669,3 k €723,9 k €449,8 k €
Other
Workforce2,0 ETP2,2 ETP2,5 ETP2,3 ETP2,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 20 ended

Active mandates

Alfred Lefever

Director · since 27 décembre 2023 · until 26 décembre 2029

Active
FARMAKS

Managing director · since 27 décembre 2023 · until 26 décembre 2029 · 0471.595.984

Represented by Kurt Lefever

Active
Sofie De Cloedt

Director · since 27 décembre 2023 · until 26 décembre 2029

Active

Ended mandates

Alfred Lefever

Director · since 09 octobre 2020 · until 27 février 2026

Ended
Sofie De Cloedt

Director · since 09 octobre 2020 · until 27 février 2026

Ended
APOTHEEK KALVEKEETDIJK

Director · since 01 juillet 2017 · until 30 juin 2022 · 0821.658.294

Represented by Kurt Lefever

Ended
APOTHEEK KALVEKEETDIJK

Director · since 01 juillet 2017 · until 30 juin 2022 · 0821.658.294

Represented by Kurt Lefever

Ended

Other companies at this address

Dorpsstraat 110 8300 Knokke-Heist
CompanyCBE no.
FARMAKS● Active
0471.595.984

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year31/12/202531/12/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months15 months12 months12 months12 months12 months
Filing date29/08/202629/08/202530/04/202428/04/202329/04/202226/04/2021
General meeting25/06/202626/06/202528/03/202431/03/202331/03/202226/03/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202525/06/202629/08/2026DutchPDF
Abridged model31/12/202426/06/202529/08/2025DutchPDF
Abridged model30/09/202328/03/202430/04/2024DutchPDF
Abridged model30/09/202231/03/202328/04/2023DutchPDF
Abridged model30/09/202131/03/202229/04/2022DutchPDF
Abridged model30/09/202026/03/202126/04/2021DutchPDF
Abridged model30/09/201928/02/202030/04/2020DutchPDF
Abridged model30/09/201801/03/201929/03/2019DutchPDF
Abridged model30/09/201702/03/201827/04/2018DutchPDF
Abridged model30/09/201603/03/201721/03/2017DutchPDF
Abridged model30/09/201504/03/201617/03/2016DutchPDF
Abridged model30/09/201406/03/201524/03/2015DutchPDF
Abridged model30/09/201307/03/201430/04/2014DutchPDF
Abridged model30/09/201201/03/201318/04/2013DutchPDF
Abridged model30/09/201102/03/201223/04/2012DutchPDF
Abridged model30/09/201004/03/201129/03/2011DutchPDF
Abridged model30/09/200905/03/201015/03/2010DutchPDF
Abridged model30/09/200806/03/200927/04/2009DutchPDF
Abridged model30/09/200707/03/200802/04/2008DutchPDF
Abridged model30/09/200602/03/200728/03/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 20 ended

Active mandates

Alfred Lefever

Director · since 27 décembre 2023 · until 26 décembre 2029

Active
FARMAKS

Managing director · since 27 décembre 2023 · until 26 décembre 2029 · 0471.595.984

Represented by Kurt Lefever

Active
Sofie De Cloedt

Director · since 27 décembre 2023 · until 26 décembre 2029

Active

Ended mandates

Alfred Lefever

Director · since 09 octobre 2020 · until 27 février 2026

Ended
Sofie De Cloedt

Director · since 09 octobre 2020 · until 27 février 2026

Ended
APOTHEEK KALVEKEETDIJK

Director · since 01 juillet 2017 · until 30 juin 2022 · 0821.658.294

Represented by Kurt Lefever

Ended
APOTHEEK KALVEKEETDIJK

Director · since 01 juillet 2017 · until 30 juin 2022 · 0821.658.294

Represented by Kurt Lefever

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates25/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates04/01/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares21/02/2012
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Mandates23/05/2006
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/05/2004
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates07/01/2003
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares27/09/2002
    ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BOEKJAAR
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202524,1 k €↓
  2. 2024
    Annual accounts 202445,6 k €↑
  3. 2023
    Annual accounts 2023-56,6 k €↓
  4. 2022
    Annual accounts 202234,6 k €↑
  5. 2021
    Annual accounts 20216,7 k €↓
  6. 2020
    Annual accounts 202012,6 k €↑
  7. 2019
    Annual accounts 2019-195,9 €↓
  8. 2018
    Annual accounts 2018114,7 k €↓
  9. 2017
    Annual accounts 2017133,9 k €↓
  10. 2016
    Annual accounts 2016147,6 k €↓
  11. 2015
    Annual accounts 2015151,8 k €↑
  12. 2014
    Annual accounts 2014142,1 k €↓
  13. 2013
    Annual accounts 2013178,3 k €↑
  14. 2012
    Annual accounts 2012123,3 k €↑
  15. 2011
    Annual accounts 201198,8 k €↑
  16. 2010
    Annual accounts 201083,2 k €↑
  17. 2009
    Annual accounts 200960,3 k €↓
  18. 2008
    Annual accounts 200870,4 k €↓
  19. 2007
    Annual accounts 200772,9 k €
  20. 24/12/1980
    IncorporationPublic limited company